Clinical Pharmacology of Current and Future Drugs for the Acute Treatment of Migraine: A Review and an Update

Keyphrases

• Triptans 100%
• Migraine Treatment 100%
• Acute Treatment 100%
• Clinical Pharmacology 100%
• Tolerability 66%
• Migraine 66%
• Migraine Patients 66%
• Adverse Events 33%
• Placebo 33%
• Phase II Study 33%
• Pharmacokinetics 33%
• Patient Needs 33%
• Common Disease 33%
• Patient Use 33%
• CGRP Antagonist 33%
• Prokinetic Drugs 33%
• NSAID Drugs 33%
• Female Prevalence 33%
• CGRP Receptor Antagonists 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Migraine 100%
• Clinical Pharmacology 100%
• Triptan Derivative 60%
• Prevalence 40%
• Tolerability 40%
• Calcitonin Gene Related Peptide Receptor Antagonist 40%
• Disease 20%
• Adverse Event 20%
• Placebo 20%
• Pharmacokinetics 20%
• Non-Steroidal Anti-Inflammatory Drug 20%